IP Library › Granted Patent US 11,525,117
Granted Patent B2
US 11,525,117 · App. 16/393,671 · Granted Dec 13, 2022

Microbial stem cell technology

Inventors: Grant Bowman (Laramie, WY); Nikolai Mushnikov (Laramie, WY); Mark Gomelsky (Laramie, WY)
Assignee: University of Wyoming
C12N1/20C12N15/86C12N2529/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,525,117
App. No.
16/393,671
Granted
Dec 13, 2022
Kind
B2
Abstract

The present disclosure relates to microbial stem cell technology that enables a growing microbial culture to stably maintain two or more distinct cell types in a ratio that can be genetically programmed and/or dynamically controlled during cultivation. It is contemplated that embodiments described herein can be utilized to increase product yield in microbial fermentations and advanced engineering of biomaterials using genetically engineered microbial cells, among others.

Claims (10)

1. A method of establishing bacterial cell types, comprising:

transforming bacterial cells with a genetic circuit, the genetic circuit comprising a sequence encoding:

a polar organizing protein comprising PopZ exhibiting an asymmetric localization pattern as a basis for asymmetric cell division, the asymmetric cell division facilitating establishment of distinct cell types within a population of bacterial cells; and

a signaling factor comprising an enzyme that catalyzes production of c-di-GMP, cAMP, c-di-AMP, cGMP and/or c-di-AMP/GMP, wherein the signaling factor is linked to the localization factor to form a complex, the complex eliciting different cell behavior in bacterial cells that inherit and express the complex versus bacterial cells that do no inherit or express the complex; and

allowing the bacterial cells to express the complex.

2. The method of claim 1 , wherein the polar organizing protein self-assembles into a macromolecular structure.

3. The method of claim 1 , wherein the signaling factor is a kinase.

4. The method of claim 1 , wherein the signaling factor is a phosphatase.

5. The method of claim 1 , wherein bacterial cells expressing the complex are non-productive of an enzyme of a biosynthetic pathway.

6. The method of claim 5 , wherein bacterial asymmetric cell division is used to induce production of the enzyme of the biosynthetic pathway in bacterial cells that lack the complex.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 2, 2022
From: UNIVERSITY OF WYOMING
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061047/0377 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2019
From: BOWMAN, GRANT; MUSHNIKOV, NIKOLAI; GOMELSKY, MARK
To: UNIVERSITY OF WYOMING
Reel/Frame 049031/0918 →
Continuity (3)
Provisional Application 62712857 · Jul 31, 2018
Provisional Application 62661818 · Apr 24, 2018
Related Publication 20190322980A1 · Oct 24, 2019